248 related articles for article (PubMed ID: 36098712)
21. Differential Expression Profiles and Function Prediction of Transfer RNA-Derived Fragments in High-Grade Serous Ovarian Cancer.
Chen B; Liu S; Wang H; Li G; Lu X; Xu H
Biomed Res Int; 2021; 2021():5594081. PubMed ID: 33860037
[TBL] [Abstract][Full Text] [Related]
22. lnc-PKD2-2-3, identified by long non-coding RNA expression profiling, is associated with pejorative tumor features and poor prognosis, enhances cancer stemness and may serve as cancer stem-cell marker in cholangiocarcinoma.
Qiu G; Ma D; Li F; Sun D; Zeng Z
Int J Oncol; 2019 Jul; 55(1):45-58. PubMed ID: 31059014
[TBL] [Abstract][Full Text] [Related]
23. A comprehensive expression profile of tRNA-derived fragments in papillary thyroid cancer.
Shan S; Wang Y; Zhu C
J Clin Lab Anal; 2021 Mar; 35(3):e23664. PubMed ID: 33332661
[TBL] [Abstract][Full Text] [Related]
24. Differential expression spectrum and targeted gene prediction of tRNA-derived small RNAs in idiopathic pulmonary arterial hypertension.
Chen Y; Tang Y; Hou S; Luo J; Chen J; Qiu H; Chen W; Li K; He J; Li J
Front Mol Biosci; 2023; 10():1204740. PubMed ID: 37496778
[No Abstract] [Full Text] [Related]
25. HSDL2 knockdown promotes the progression of cholangiocarcinoma by inhibiting ferroptosis through the P53/SLC7A11 axis.
Ma S; Ma Y; Qi F; Lei J; Chen F; Sun W; Wang D; Zhou S; Liu Z; Lu Z; Zhang D
World J Surg Oncol; 2023 Sep; 21(1):293. PubMed ID: 37718459
[TBL] [Abstract][Full Text] [Related]
26. Knockdown of tripartite motif 59 (TRIM59) inhibits proliferation in cholangiocarcinoma via the PI3K/AKT/mTOR signalling pathway.
Shen H; Zhang J; Zhang Y; Feng Q; Wang H; Li G; Jiang W; Li X
Gene; 2019 May; 698():50-60. PubMed ID: 30822475
[TBL] [Abstract][Full Text] [Related]
27. Plasma tRNA-derived small RNAs signature as a predictive and prognostic biomarker in lung adenocarcinoma.
Wang J; Liu X; Cui W; Xie Q; Peng W; Zhang H; Gao Y; Zhang C; Duan C
Cancer Cell Int; 2022 Feb; 22(1):59. PubMed ID: 35115004
[TBL] [Abstract][Full Text] [Related]
28. CHST4 might promote the malignancy of cholangiocarcinoma.
Zhang G; Liu X; Jian A; Zheng K; Wang H; Hao J; Zhi S; Zhang X
PLoS One; 2022; 17(3):e0265069. PubMed ID: 35294478
[TBL] [Abstract][Full Text] [Related]
29. The role of Transfer RNA-Derived Small RNAs (tsRNAs) in Digestive System Tumors.
Wang BG; Yan LR; Xu Q; Zhong XP
J Cancer; 2020; 11(24):7237-7245. PubMed ID: 33193887
[TBL] [Abstract][Full Text] [Related]
30. tRNA‑derived small RNAs: A novel class of small RNAs in human hypertrophic scar fibroblasts.
Zhang Y; Deng Q; Tu L; Lv D; Liu D
Int J Mol Med; 2020 Jan; 45(1):115-130. PubMed ID: 31939611
[TBL] [Abstract][Full Text] [Related]
31. ARHGAP21 Is Involved in the Carcinogenic Mechanism of Cholangiocarcinoma: A Study Based on Bioinformatic Analyses and Experimental Validation.
Wang Z; Wu S; Wang G; Yang Z; Zhang Y; Zhu C; Qin X
Medicina (Kaunas); 2023 Jan; 59(1):. PubMed ID: 36676763
[No Abstract] [Full Text] [Related]
32. Differential Expression Profiles and Function Predictions for tRFs & tiRNAs in Skin Injury Induced by Ultraviolet Irradiation.
Fang Y; Liu Y; Yan Y; Shen Y; Li Z; Li X; Zhang Y; Xue Z; Peng C; Chen X; Cao K; Zhou J
Front Cell Dev Biol; 2021; 9():707572. PubMed ID: 34447751
[TBL] [Abstract][Full Text] [Related]
33. Upregulation of miR‑132‑3p in cholangiocarcinoma tissues: A study based on RT‑qPCR, The Cancer Genome Atlas miRNA sequencing, Gene Expression Omnibus microarray data and bioinformatics analyses.
Wu HY; Xia S; Liu AG; Wei MD; Chen ZB; Li YX; He Y; Liao MJ; Hu QP; Pan SL
Mol Med Rep; 2019 Dec; 20(6):5002-5020. PubMed ID: 31638221
[TBL] [Abstract][Full Text] [Related]
34. Global profile of tRNA-derived small RNAs in gastric cancer patient plasma and identification of tRF-33-P4R8YP9LON4VDP as a new tumor suppressor.
Shen Y; Yu X; Ruan Y; Li Z; Xie Y; Yan Z; Guo J
Int J Med Sci; 2021; 18(7):1570-1579. PubMed ID: 33746573
[TBL] [Abstract][Full Text] [Related]
35. MCM2 promotes the proliferation, migration and invasion of cholangiocarcinoma cells by reducing the p53 signaling pathway.
Wang CL; Liu XY; Wang YH; Zhang Z; Wang ZD; Zhou GQ
Yi Chuan; 2022 Mar; 44(3):230-244. PubMed ID: 35307646
[TBL] [Abstract][Full Text] [Related]
36. Identification and Validation of Novel Biomarkers and Potential Targeted Drugs in Cholangiocarcinoma: Bioinformatics, Virtual Screening, and Biological Evaluation.
Wang J; Zhu W; Tu J; Zheng Y
J Microbiol Biotechnol; 2022 Oct; 32(10):1262-1274. PubMed ID: 36224755
[TBL] [Abstract][Full Text] [Related]
37. A metabolism-related 4-lncRNA prognostic signature and corresponding mechanisms in intrahepatic cholangiocarcinoma.
Zou W; Wang Z; Wang F; Li L; Liu R; Hu M
BMC Cancer; 2021 May; 21(1):608. PubMed ID: 34034689
[TBL] [Abstract][Full Text] [Related]
38. Genome-wide identification of a competing endogenous RNA network in cholangiocarcinoma.
Li G; Liu T; Zhang B; Chen W; Ding Z
J Cell Biochem; 2019 Nov; 120(11):18995-19003. PubMed ID: 31270845
[TBL] [Abstract][Full Text] [Related]
39. Comprehensive circular RNA expression profiling constructs a ceRNA network and identifies hsa_circ_0000673 as a novel oncogene in distal cholangiocarcinoma.
Zhao X; Zhang X; Zhang Z; Liu Z; Zhu J; Lyu S; Li L; Lang R; He Q
Aging (Albany NY); 2020 Nov; 12(22):23251-23274. PubMed ID: 33221765
[TBL] [Abstract][Full Text] [Related]
40. cDNA microarray profiling of rat cholangiocarcinoma induced by thioacetamide.
Yeh CN; Weng WH; Lenka G; Tsao LC; Chiang KC; Pang ST; Chen TW; Jan YY; Chen MF
Mol Med Rep; 2013 Aug; 8(2):350-60. PubMed ID: 23754683
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
